Tate & Lyle PLC
16 February 2001
Tate & Lyle PLC - Agreement to sell share in Zambia Sugar Plc
Tate & Lyle PLC announced on 16 February 2001 that it has agreed, subject to
the completion of satisfactory due diligence and approval by the Securities
and Exchange Commission of Zambia and the Zambian Competition Commission, to
sell its 50.87% share in Zambia Sugar Plc for US$11.4 million (£7.9 million)
to Illovo Sugar Limited ('Illovo'). The sale proceeds will be used to pay down
Group debt.
Following completion of the sale, Illovo will extend an equivalent offer to
all other shareholders of Zambia Sugar Plc. An announcement confirming the
results of Illovo's due diligence will be made in approximately two weeks. The
price remains subject to due diligence review.
Larry Pillard, Chief Executive Tate & Lyle PLC said:
'This transaction is another step in our objective to exit those businesses
that we cannot successfully develop further to enable us to build our value
added product portfolio.'
For further information please contact:
Mark Robinson + 44 (0) 20 7626 6525
Chris Fox + 44 (0) 20 7626 6525 (Press)
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.